The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Progression-free survival estimates in non-small cell lung cancer when RECIST is unavailable: Project GENIE’s integration of genomic, therapeutic and phenomic data.
 
Jessica A. Lavery
Other Relationship - AACR (Inst)
 
Katherine Panageas
Stock and Other Ownership Interests - AstraZeneca; Catalyst Biotech; Dynavax Technologies; Pfizer; Sunesis Pharmaceuticals; Viking Therapeutics
 
Michele LeNoue-Newton
No Relationships to Disclose
 
Shawn Sweeney
No Relationships to Disclose
 
Seth Sheffler-Collins
No Relationships to Disclose
 
Julia E Rudolph
No Relationships to Disclose
 
Hira Rizvi
No Relationships to Disclose
 
Nikolaus Schultz
No Relationships to Disclose
 
Eva M. Lepisto
No Relationships to Disclose
 
Kenneth L. Kehl
Consulting or Advisory Role - Aetion
 
Jeremy Lyle Warner
Stock and Other Ownership Interests - HemOnc.org
Consulting or Advisory Role - IBM; Westat
Travel, Accommodations, Expenses - IBM
 
Kristen Dang
No Relationships to Disclose
 
John Phillip
No Relationships to Disclose
 
Ben Ho Park
Leadership - Loxo
Stock and Other Ownership Interests - Celcuity; Loxo
Honoraria - AstraZeneca
Consulting or Advisory Role - Casdin Capital; Celcuity; Foundation Medicine; H3 Biomedicine; Horizon Discovery; Jackson Laboratory for Genomic Medicine; Lilly; Loxo
Research Funding - Abbvie; Foundation Medicine; GE Healthcare; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties paid through inventions at Johns Hopkins University by Horizon Discovery LTD
Travel, Accommodations, Expenses - Lilly; Loxo
(OPTIONAL) Uncompensated Relationships - Tempus
 
Gregory J. Riely
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
Other Relationship - Pfizer; Roche/Genentech; Takeda
 
Deborah Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - JAMA-Journal of the American Medical Association
Research Funding - AACR (Inst); GRAIL (Inst); Pfizer
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.
Travel, Accommodations, Expenses - IMEDEX; Precision Medicine World Conference
Other Relationship - JAMA-Journal of the American Medical Association